Synthon IP Inc.
Records under this name other than patents Synthon IP Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,776,358 | Extended release venlafaxine besylate tablets Formerly held In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 7,018,658 | Pharmaceutical pellets comprising tamsulosin Formerly held Term ended Term ended Nov 29, 2023 · From the USPTO record | Term ended | Term ended Nov 29, 2023 | From the USPTO record |
| US 6,717,015 | Venlafaxine besylate Formerly held Term ended Term ended Mar 27, 2023 · From the USPTO record | Term ended | Term ended Mar 27, 2023 | From the USPTO record |
| US 7,491,848 | Process for making desvenlafaxine Lapsed on the fee record Ended Feb 17, 2017 · From the USPTO record | Lapsed on the fee record | Ended Feb 17, 2017 | From the USPTO record |
| US 6,703,408 | N-formyl derivatives of paroxetine Lapsed on the fee record Ended Mar 9, 2016 · From the USPTO record | Lapsed on the fee record | Ended Mar 9, 2016 | From the USPTO record |
| US 7,829,716 | Process for making montelukast and intermediates therefor Lapsed on the fee record Ended Nov 9, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 9, 2014 | From the USPTO record |
| US 6,965,051 | Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith Lapsed on the fee record Ended Nov 15, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 15, 2013 | From the USPTO record |
| US 6,242,460 | Zolpidem salt forms Lapsed on the fee record Ended Jun 5, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2013 | From the USPTO record |
| US 7,541,470 | Processes for making pioglitazone and compounds of the processes Lapsed on the fee record Ended Jun 2, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jun 2, 2013 | From the USPTO record |
| US 7,501,517 | Process for making montelukast and intermediates therefor Lapsed on the fee record Ended Mar 10, 2013 · From the USPTO record | Lapsed on the fee record | Ended Mar 10, 2013 | From the USPTO record |